| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1183346A4 Method for generating split, non-transferable genes that are able to express an active protein product |
| 08/18/2004 | EP0877622B1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | CN1522516A Secure header information for multi-content e-mail |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522156A Novel engineered superantigen for human therapy |
| 08/18/2004 | CN1521192A Human erythropoietin Fc fusion protein with high bioactivity |
| 08/18/2004 | CN1521191A Recombinant protein molecule for inhibiting attack and transfer of cancer cell and angiogenesis |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/17/2004 | CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157216 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 08/12/2004 | US20040157215 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040157214 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040156864 Immunogenic HBc chimer particles having enhanced stability |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/11/2004 | EP1444986A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/11/2004 | EP1444349A2 Process for the preparation of ramipril |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444250A1 Groel chimeric protein and vaccine |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1326881A4 PREPARATION OF CAPPED mRNA |
| 08/11/2004 | EP1242457B1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 08/11/2004 | EP0867450B1 TFPI-related Peptides which inhibit growth of smooth muscle cells |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | CN1161467C Fusion protein with function of resisting tumor and its application |
| 08/11/2004 | CN1161465C Chimeric proteins for use in transport of selected substance into cells |
| 08/11/2004 | CN1161464C Human epidermal growth factor recetor specitic fusion protein and its application |
| 08/11/2004 | CN1161375C Fusion protein with improved combining activity to target cell receptor |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774214 Monocyte-derived homolog of FDF03 protein |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/07/2004 | CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/05/2004 | WO2004040262A3 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | US20040152876 Immunogenic HBc chimer particles having enhanced stability |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040151720 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/05/2004 | US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens |
| 08/04/2004 | EP1442134A2 Method for producing and identifying soluble protein domains |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1285054B1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 08/04/2004 | EP1133564B1 Zace1: a human metalloenzyme |
| 08/04/2004 | CN1517437A Vaccine for specificity treating tumour or endocellular infection and application |
| 08/04/2004 | CN1517365A Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |
| 08/04/2004 | CN1160463C Human papillomaivirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/03/2004 | US6770798 Transformed plants conferring on them resistance to diseases of fungal origin |
| 08/03/2004 | US6770631 Non-identical genes and their application in improved molecular adjuvants |
| 07/29/2004 | WO2004062619A2 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 07/29/2004 | WO2004052930A3 Targeting single epitopes |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | US20040147721 Antigens and vectors for vaccination |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146985 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146969 Process for producing recombinant protein and fused protein |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440156A2 Antigens and vectors for vaccination |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP0935607B1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 07/28/2004 | CN1516734A Transformed silkworm producing human collagen |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |